UCLA Mattel Children ’s Hospital helps kids trick-or-treat

Three-year-old Harmon Jones strutted in his “Black Panther” costume as he prowled the UCLA Mattel Children’s Hospital hallways and main lobby for treats. After watching a special magic show and playing some tunes led by music therapists, he wanted some Halloween candy.“My favorite part is the lollipops!” Harmon said. “I like to share them with my mommy and daddy!”For Heather and Shaw Jones, Harmon ’s parents, holidays bring some sense of the normal and community. Last summer, Harmon was diagnosed with rhabdomyosarcoma, a rare cancer that forms in soft tissue — specifically skeletal muscle tissue or sometimes in hollow organs such as the bladder or uterus.“We have spent close to 64 weeks in the hospital,” Heather said. “This is all Harmon knows. The Chase Child Life team, our nurses, and the entire campus has come out in droves to make sure Harmon and other patients feel as if they are trick-or-treating in our home neighborhood.”The  Chase Child Life Program organized the celebration at UCLA Mattel Children’s Hospital, ensuring that any children in the hospital who wanted to could experience some Halloween fun.It was a UCLA community effort, with nearly 65 campus departments and groups dressed up as characters from “Toy Story,” “Inside Out,” “Minions,” “Paw Patrol,” “Harry Potter,” among other outfits.“It really is so b...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

Osteosarcoma (OS) is the most common primary bone malignancy and is a leading cause of cancer-related death in children and young adults. Combination chemotherapy developed 3 decades ago significantly improved long-term survival compared to surgery alone. However, despite notable tumor cytoreduction and remission, the 5-year survival rate has remained static at ∼70% since, and the surviving patients have high chemoresistance with sustained risk of recurrent OS that has propensity to metastasize. After metastasis, the 5-year survival rate is abysmally low (∼10% to 20%). Emerging new evidence has revealed that within...
Source: Techniques in Orthopaedics - Category: Orthopaedics Tags: Symposium Source Type: research
Authors: Philip T, Karjalainen S, De Lorenzo F, Apostolidis K, Lombardo C, Nilbert M, Lacombe D, Poortmans P, Albreht T, Kearns P, Vassal G Abstract The European cancer burden is growing rapidly, with an estimated 2 million deaths a year according to the latest research. As almost half of cancers are diagnosed after the age of 65, and considering the aging European population, a tidal wave of cancer cases will sweep across Europe within the coming decades. Without major action, the additional number of annual cancer cases is expected to rise from 4.2 million to 5.2 million by 2040. If we are to reach plateauing num...
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research
Guardant Health isn’t a static company. Ever since it was formed by Helmy Eltoukhy, and AmirAli Talasaz, the Redwood City, CA-based company has been setting the bar in the liquid biopsy space. So whether it’s making the transition from private to public; posting up strong data; raking in large funding during past financing rounds, or introducing new cancer detection technologies into the market, the company is on the move and reaching milestones. The latest goal Guardant has set its sights on is winning U.S. approval for its Lunar-2 test. The liquid biopsy test will be used in early colo...
Source: MDDI - Category: Medical Devices Authors: Tags: IVD Source Type: news
Conclusion: These findings cannot support contribution of rs1042522 polymorphism to breast cancer risk in an Iranian population. Future larger studies may help confirm this finding with a greater power. PMID: 31721533 [PubMed]
Source: Cancer Control - Category: Cancer & Oncology Authors: Tags: Cell J Source Type: research
Authors: Vahl JM, Schuler PJ, Greve J, Laban S, Knopf A, Hoffmann TK Abstract Total laryngectomy provides a curative approach for patients with advanced laryngeal and hypopharyngeal cancer without distant metastasis. Especially in stage cT4a disease, laryngectomy is superior to primary radio(chemo)therapy in retrospective studies. Further relevant indications for the procedure are tumor-related laryngeal dysfunction such as dysphagia and aspiration, as well as cancer recurrence after primary radio(chemo)therapy. The surgical procedure is highly standardized, with an appropriate safety profile. The subsequent l...
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research
No abstract available
Source: Diseases of the Colon and Rectum - Category: Gastroenterology Tags: Viewpoints Source Type: research
CONCLUSIONS: Receipt of the open or laparoscopic surgical technique was not associated with increased risk of elevated symptom burden in the early postdischarge period. See Video Abstract at http://links.lww.com/DCR/B27. REPORTE COMPARATIVO DE RESULTADOS INFORMADOS DE PACIENTES CON HEMICOLECTOMÍA DERECHA LAPAROSCÓPICA Y ABIERTA: UN ESTUDIO DE COHORTE RETROSPECTIVO ANTECEDENTES: Las resecciones abiertas y laparoscópicas para el cáncer de colon, presentan semejante morbilidad y mortalidad perioperatoria. Sin embargo, en el período inicial posterior al alta, hay pocos datos sobre los r...
Source: Diseases of the Colon and Rectum - Category: Gastroenterology Tags: Original Contributions: Colorectal Cancer Source Type: research
This study aimed to compare and analyze the patterns of care and survival outcomes of patients with anal squamous cell carcinoma and anal adenocarcinoma. DESIGN: This was a retrospective study. SETTING: This study was performed by utilizing the National Cancer Database. PATIENTS: We selected a total of 19,539 patients between 2004 and 2014 with stage II to III squamous cell carcinoma or adenocarcinoma of the anus. INTERVENTION: The treatment groups analyzed were surgery alone, neoadjuvant chemoradiation followed by surgery, surgery followed by adjuvant chemoradiation, or definitive chemoradiation. MAIN OUTCOME...
Source: Diseases of the Colon and Rectum - Category: Gastroenterology Tags: Original Contributions: Colorectal Cancer Source Type: research
Conclusions: The proposed nomogram is a reliable and robust tool for accurate prognostic prediction in patients with extremity soft tissue LMS. Introduction Soft tissue leiomyosarcoma (LMS) is an aggressive sarcoma, which originates from smooth muscle cells (1). Soft tissue LMS accounts for about 5–10% of all soft tissue sarcomas (2). It occurs in different sites, including the retroperitoneum, intraabdominal sites, and extremities (3). Extremity LMS comprised about 10–15% of extremity sarcomas, with a preference for the lower limb (4–6). Extremity LMS tends to have a better prognosis than uterine...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
In conclusion, osmotic burst of inflated complement-damaged cells may occur, but these bursts are most likely a consequence of metabolic collapse of the cell rather than the cause of cell death. The Complement Cell Death Mediator: A Concerted Action of Toxic Moieties Membrane pores caused by complement were first visualized by electron microscopy on red blood cell membranes as large ring structures (22). Similar lesions were viewed on E. coli cell walls (23). Over the years, ample information on the fine ultrastructure of the MAC that can activate cell death has been gathered (24) and has been recently further examined (...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Cancer of the Uterus | Children | Hospitals | Music Therapy | Nurses | Nursing | Pediatrics | Rhabdomyosarcoma | Students | Universities & Medical Training